prenatal diagnosis (pnd) in joubert syndrome
DESCRIPTION
Prenatal diagnosis (PND) in Joubert syndrome. Goals of PND. Provide reassurance/reduce uncertainty Prepare for the birth of an affected child Delivery route Delivery location Emotional preparation Assure the birth of an unaffected child Pregnancy termination - PowerPoint PPT PresentationTRANSCRIPT
Prenatal diagnosis (PND) in
Joubert syndrome
Goals of PND
• Provide reassurance/reduce uncertainty• Prepare for the birth of an affected child
– Delivery route– Delivery location– Emotional preparation
• Assure the birth of an unaffected child– Pregnancy termination– (Preimplantation genetic diagnosis)
• Allow for prenatal treatment
JS is autosomal recessive*
Recurrence risk = 25%
Reproductive options• Accept the risk without PND
Reproductive options• Accept the risk without PND• Accept the risk and consider PND:
– To prepare for an affected child– To terminate an affected pregnancy
Reproductive options• Accept the risk without PND• Accept the risk and consider PND:
– To prepare for an affected child– To terminate an affected pregnancy
• Sperm or egg donor to reduce risk
Reproductive options• Accept the risk without PND• Accept the risk and consider PND:
– To prepare for an affected child– To terminate an affected pregnancy
• Sperm or egg donor to reduce risk• Choose to adopt
Reproductive options• Accept the risk without PND• Accept the risk and consider PND:
– To prepare for an affected child– To terminate an affected pregnancy
• Sperm or egg donor to reduce risk• Choose to adopt• Choose not to have additional children
Reproductive options• Accept the risk without PND• Accept the risk and consider PND:
– To prepare for an affected child– To terminate an affected pregnancy
• Sperm or egg donor to reduce risk• Choose to adopt• Choose not to have additional children
ALL of these choices are valid.
Risk scenarios• Prior affected child: 25% risk each pregnancy
– Clinical diagnosis only -> prenatal imaging– Clinical and genetic diagnosis -> genetic testing and
prenatal imaging
• No family history: population risk (very low)– Routine prenatal care
• Population risk of birth defects 2-3%
Testing Strategies
• Available–Prenatal imaging–Fetal DNA testing (amniotic fluid or CVS)
• Not Available–Maternal serum screening–Biochemical testing (amniotic fluid)
Imaging diagnosis
• Consistent finding– Cerebellar vermis hypoplasia
• Molar tooth sign not seen before 24 weeks
• Supportive findings (rare)– Polydactyly– Cystic kidneys– Encephalocele– Increased respiratory rate
Vermis hypoplasia US
Superior vermisintact
Inferior vermisabsent
Vermis hypoplasia fetal MRI
21 wksAffected
22 wksUnaffected
Molar tooth sign in utero
29 wks gestation Post-natal
Polydactyly in utero
123
4
5
6
Aslan et al. 2002
Encephalocele in utero
Fetal MRI (JS)US (not JS)
Specific imaging strategy
• Usual prenatal care and screening• Consultation with a tertiary care center• 16-18 week US• 20 week US• 20-22 week fetal MRI
adapted from Doherty et al. 2005
We are happy to consult with OB providers/radiologists about imaging diagnosis. We prefer to be involved starting before/early in the pregnancy.
Imaging diagnosis• Advantages:
– Non-invasive– Can visualize brain, fingers, kidneys– Can be repeated throughout pregnancy– Relatively inexpensive
• Disadvantages:– Technician-dependent– Radiologist-dependent– May not see subtle abnormalities – Late diagnosis
Background: Genetic TestingGene Estimated frequencyNPHP1 ~2% AHI1 ~10% CEP290 ~10%RPGRIP1L ~5% MKS3 ~10%ARL13B <1%CC2D2A ~10% INPP5E ? TMEM216 ~ 4%MKS1 ~ 2%OFD1 <1% TOTAL <50%
Frequency of mutations in patients with JS
DNA testing strategy• Test affected child prior to next pregnancy
DNA testing strategy• Test affected child prior to next pregnancy• Test affected child prior to next pregnancy
DNA testing strategy• Test affected child prior to next pregnancy• Test affected child prior to next pregnancy• No mutation identified -> PND by imaging
DNA testing strategy• Test affected child prior to pregnancy• Test affected child prior to pregnancy• No mutation identified -> PND by imaging• Mutation identified
– Preimplantation genetic diagnosis– Chorionic villous sampling– Amniocentesis
DNA collection techniques
• early placental tissue• 10-12wk gestation• Risks:
– Miscarriage (1/100) – Infection
• Less available in US• DNA dx 12-14 wks
Chorionic villus sampling
DNA collection techniquesAmniocentesis• fetal skin cells in fluid• >15 wk gestation• Risks:
– Miscarriage (1/500)– Infection– Fluid leak– Fetal injury
• DNA dx ~20+ wks
Making a Decision
• Genetic Counselor or Geneticist can help– Discuss options– Provide resources and support
• Consider contacting them before pregnancy or early in pregnancy
• See www.nsgc.org for a list of local GC’s
• Family history of JS– Known mutation -> PND by gene testing– No mutation -> PND by prenatal US & fetal MRI
• No family history– JS not distinguishable from other cerebellar vermis
hypoplasias before 24wks– Variable features can facilitate diagnosis
• Encephalocele, polydactyly, cystic kidneys
• After 27wks, dx possible by imaging alone
Conclusions
Acknowledgements
University of Washington Joubert Center http://depts.washington.edu/joubert/